Note 19 - Operations and Industry Segments and Geographic Areas (Detail) (USD $)	12 Months Ended
	Sep. 29, 2012	Oct. 01, 2011	Oct. 02, 2010
Number of Reportable Segments	2
Concentration Risk, Percentage	34.00%	28.00%	26.00%
Medical [Member] | Sales Revenue, Product Line [Member]
Concentration Risk, Percentage	21.00%	28.00%	28.00%
Custom Products [Member] | Sales Revenue, Product Line [Member]
Concentration Risk, Percentage	88.00%	83.00%	82.00%
Canada [Member]
Assets, Net (in Dollars)	12,000,000